Daptomycin Injection, Powder, Lyophilized, For Solution
Product Images NDC 72603-147

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Daptomycin (NDC 72603-147). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northstar Rxllc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton-label (Carton Label)

Packaging label for Daptomycin for Injection 350 mg per vial, a lyophilized powder for intravenous injection. The label indicates the product must be refrigerated and reconstituted with 7 mL of 0.9% sodium chloride injection to a final concentration of 50 mg/mL. This single-dose vial is manufactured by NorthStar Rx LLC and Aspiro Pharma Limited.*

FDA Label Image

Structure (Dapto Structure)

Chemical structure of daptomycin, illustrating its complex cyclic lipopeptide molecular arrangement with multiple amino acid residues and a lipid tail.*

FDA Label Image

Vial-label (Vial Label)

Label for Daptomycin for Injection, 350 mg per vial, lyophilized powder for intravenous use. The label indicates refrigeration is required and the vial is single-dose. Manufactured for NorthStar Rx LLC and by Aspiro Pharma Limited, India. Includes storage instructions, lot and expiration placeholders, and a barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.